Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Heart Surgery Liposomes-containing-a-cisplatin-compound

 Ultrasonic sensors for monitoring the condition of a vascular graft
The invention in which an exclusive right is claimed is defined by the following: 1. A graft ...


 System and method for bidirectional flow and controlling fluid flow in a conduit
OF THE INVENTION Reference is now made to the embodiment illustrated in FIG. 1 as it might appear ...


 Endoluminal implant with fluid flow sensing capability
The invention in which an exclusive right is claimed is defined by the following: 1. An endoluminal ...


 Cantilever having sensor system for independent measurement of force and torque
It has now been discovered, that improved operation and capabilities of a cantilever measuring ...


 Blood flow conduit delivery system and method of use
The problem of delivering an L-shaped shunt or conduit is solved herein by providing an improved ...


 Cable attachment for a radioactive brachytherapy source capsule
It is a first object of the invention to provide a capsule/cable attachment without welds, thereby ...


 Flexible coil pulsed electromagnetic field (PEMF) stimulation therapy system
Various aspects of the invention are directed to a PEMF therapy system having a transducer coil for ...


 Actuator element
The invention achieves this object by providing an actuator element comprising an ion exchange ...


 Self lubricating sex aids
In this respect, the sex aids according to the present invention substantially depart from the ...


 Apparatuses and methods for extravasation detection
The present invention provides generally a device and method for the detection of extravasation in ...


 Liposomes containing a cisplatin compound

Details
Inventors: Abra, Robert M.; Reis, Karen;
Assignee: Sequus Pharmaceuticals, Inc. (Menlo Park, CA)
Primary Examiner: Kishore; Gollamudi S.
Assistant Examiner:
Attorney, Agent or Firm: Mohr; Judy M. Iota Pi Law Group

A liposome composition containing an entrapped cisplatin compound is described. The liposomes have a surface coating of hydrophilic polymer chains on inner and outer surfaces and an entrapped cisplatin compound. The compound is entrapped with substantially greater retention in the liposomes, when compared to liposomes lacking the polymer coating. A method of preparing the composition is also described.

DETAILED DESCRIPTION In one aspect, the invention includes a liposomal composition containing an entrapped cisplatin compound.
The composition includes liposomes having an outer surface and an inner surface defining an aqueous liposome compartment.
The liposomes are composed of a vesicle-forming lipid and between about 1-20 mole percent of a vesicle-forming lipid derivatized with a hydrophilic polymer.
The liposomes are formed such that the hydrophilic polymer forms a coating of hydrophilic polymer chains on both the inner and outer surfaces.
The cisplatin compound is entrapped in the liposomes with substantially greater retention than in liposomes lacking the inner and outer polymer surface coatings.
The cisplatin compound, in one embodiment, is native cisplatin and is entrapped in the liposomes at a drug-to-lipid ratio of between about 10 to 20 .
mu.
g/mg total lipid.
In another embodiment, the cisplatin compound is a cisplatin analogue.
In another embodiment, the hydrophilic polymer chains are composed of a hydrophilic polymer selected from the group consisting of polyvinylpyrrolidone, polyvinylmethylether, polymethyloxazoline, polyethyloxazoline, polyhydroxypropyloxazoline, polyhydroxypropylmethacrylamide, polymethacrylamide, polydimethylacrylamide, polyhydroxypropylmethacrylate, polyhydroxyethylacrylate, hydroxymethylcellulose, hydroxyethylcellulose, polyethyleneglycol, and polyaspartamide.
In a preferred embodiment, the hydrophilic polymer is polyethyleneglycol.
The liposomes, in one embodiment have sizes between about 80-160 nm, preferably 100-140 nm, most preferably between about 100-120 nm.
In a preferred embodiment, the vesicle forming lipid is hydrogenated soy phosphatidylcholine and the derivatized vesicle forming lipid is distearyl phosphatidylethanolamine derivatized with polyethylene glycol.
In another aspect, the invention includes a method of entrapping a cisplatin compound in liposomes, by heating an aqueous solution of a cisplatin compound to a temperature sufficient to increase its solubility over the compound's solubility at room temperature



Related patents
  Method for regulating a delivery variable of a pump
The invention is based on the problem of improving a method of the kind mentioned in the introduction, without direct measurement of the pressure or flow rate of the ...
  Dosimetry for californium-252 (.sup.252Cf) neutron-emitting brachytherapy sources and encapsulation, storage, and clinical delivery thereof
OF THE INVENTION In brief, the present invention discloses the novel application of an International Commission on Radiation Units and Measurements (ICRU-45)-like ...
  Peristaltic pump header
Referring to the figures of the drawing, there is shown in FIG. 1 a schematic view of a preferred embodiment of the pump header 10 of the present invention in a system 1...
  Heart stabilizer
Referring to the drawings more particularly by reference numbers, FIG. 1 shows a system 10 that can perform minimally invasive surgery. In the preferred embodiment, the ...
  Assist tool for inserting a treatment tool into an endoscope, and a treatment tool to be used in the same
It is an object of the present invention to provide an assist tool for easily and safely inserting/extracting a treatment tool into/from a treatment tool insertion ...
  Endoscope
OF THE EMBODIMENT Hereinafter, an embodiment of the present invention will be described with reference to the accompanying drawings. FIG. 1 shows an entire view of an ...
  Apparatus and method for controlling the delivery of non-excitatory cardiac contractility modulating signals to a heart
It is noted that, while generally the term ETC signal refers to non-excitatory electrical signals applied to an excitable tissue, the terms ETC signal and CCM signal are ...
  Acousto-optical ultrasonic flowmeter
The flowmeter of the present invention includes an optical window in a wall of a fluid conveyance such as a pipe. A pulsed laser apparatus is positioned to project a ...
  Passive sensor system using ultrasonic energy
OF A PREFERRED EMBODIMENT Reference is now made to FIG. 1 which illustrates the ultrasonic sensor system of the present invention. The system comprises a passive sensor ...
  Implantable medical device including an arrangement for measuring a blood property having a carbon reference electrode
We claim as our invention: 1. An implantable medical device comprising: means for making an electrochemical measurement of a blood property including a reference ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved